Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis.
Open accessThe DOI matches its Crossref record.
Abstract
Tumor necrosis factor (TNF) and interferon gamma (IFN-gamma) are pluripotent cytokines and have multiple functions during the inflammatory response. Using a murine model of autoimmune myocarditis, we studied the role of TNF and IFN-gamma in myocardial inflammation. Neutralizing monoclonal antibodies against TNF-alpha/beta and IFN-gamma were administered to myosin-immunized A/J mice to assess the effect on the severity of myocardial inflammation. Anti-TNF treatment significantly reduced the severity of myocarditis compared with rat immunoglobulin G or saline controls (p less than 0.0007) when given before myosin immunization. Myosin-specific lymph node T-cell proliferation studies showed no difference in the proliferative response between the anti-TNF-treated mice and controls. Administration of anti-TNF to mice after myosin immunization had no effect on the severity of inflammation. This suggests that TNF is an important mediator early in the pathogenesis of myocardial inflammation in this model of myocarditis. Neutralization of IFN-gamma significantly increased the severity of myocarditis compared with rat immunoglobulin G and saline controls (p less than 0.0065), suggesting that IFN-gamma may function as an important regulatory cytokine early in the pathogenesis of myocardial inflammation. Understanding the functions of cytokines during the inflammatory response to myocardial injury may provide important information on possible methods to limit myocardial damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Apoptosis: Basic Mechanisms and Implications for Cardiovascular Disease
Haunstetter, A., & Izumo, S. (1998) · Circulation Research · doi:10.1161/01.res.82.11.1111 · Cited by 807
Yokoyama, T., Vaca, L., Rossen, R. D., Durante, W., Hazarika, P., & Mann, D. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116834 · Cited by 717
Increased circulating cytokines in patients with myocarditis and cardiomyopathy.
Matsumori, A., Yamada, T., Suzuki, H., Matoba, Y., & Sasayama, S. (1994) · Heart · doi:10.1136/hrt.72.6.561 · Cited by 524
Basic Mechanisms in Congestive Heart Failure
Mann, D. L., & Young, J. B. (1994) · Chest · doi:10.1378/chest.105.3.897 · Cited by 358
Nitric oxide synthase activities in human myocardium
de Belder, A. J., Why, H. J. F., Richardson, P. J., Bucknall, C. A., Martin, J. F., Radomski, M. W., Salas, E., & Moncada, S. (1993) · The Lancet · doi:10.1016/0140-6736(93)92559-c · Cited by 353
Expression and Functional Significance of Tumor Necrosis Factor Receptors in Human Myocardium
Torre-Amione, G., Kapadia, S., Lee, J., Bies, R. D., Lebovitz, R., & Mann, D. L. (1995) · Circulation · doi:10.1161/01.cir.92.6.1487 · Cited by 340
Oral, H., Dorn, G. W., & Mann, D. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.8.4836 · Cited by 323
Stress-Activated Cytokines and The Heart: From Adaptation to Maladaptation
Mann, D. L. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142249 · Cited by 297
Kapadia, S. R., Oral, H., Lee, J., Nakano, M., Taffet, G. E., & Mann, D. L. (1997) · Circulation Research · doi:10.1161/01.res.81.2.187 · Cited by 289
Nagano, H., Mitchell, R. N., Taylor, M. K., Hasegawa, S., Tilney, N. L., & Libby, P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119564 · Cited by 275
Afanasyeva, M., Wang, Y., Kaya, Z., Park, S., Zilliox, M. J., Schofield, B. H., Hill, S. L., & Rose, N. R. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61685-9 · Cited by 175
Myocarditis in Humans and in Experimental Animal Models
Błyszczuk, P. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00064 · Cited by 161
Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus‐induced myocarditis
Fairweather, D., Frisancho‐Kiss, S., & Rose, N. R. (2005) · Reviews in Medical Virology · doi:10.1002/rmv.445 · Cited by 155
Donermeyer, D. L., Beisel, K. W., Allen, P. M., & Smith, S. C. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1291 · Cited by 140
Self-citationFairweather, D., Frisancho-Kiss, S., Gatewood, S., Njoku, D., Steele, R., Barrett, M., & Rose, N. R. (2004) · Autoimmunity · doi:10.1080/0891693042000196200 · Cited by 115
“For example, monoclonal antibody neutralization of TNF-a reduces the severity of cardiac myosin or CB3-induced myocarditis.([4,53]) Furthermore, genetically resistant strains of mice can be induced to develop chronic autoimmune disease by administration of TNF-a or IL-1b during the innate immune response to the virus.”
BackgroundAfanasyeva, M., Georgakopoulos, D., Belardi, D. F., Bedja, D., Fairweather, D., Wang, Y., Kaya, Z., Gabrielson, K. L., Rodriguez, E. R., Caturegli, P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408241102 · Cited by 89
Autoimmune Myocarditis, Valvulitis, and Cardiomyopathy
Myers, J. M., Fairweather, D., Huber, S. A., & Cunningham, M. W. (2013) · Current Protocols in Immunology · doi:10.1002/0471142735.im1514s101 · Cited by 63
McTiernan, C. F., Mathier, M. A., Zhu, X., Xiao, X., Klein, E., Swan, C. H., Mehdi, H., Gibson, G., Trichel, A. M., Glorioso, J. C., et al. (2007) · Gene Therapy · doi:10.1038/sj.gt.3303020 · Cited by 40
Krishnan, B., Massilamany, C., Basavalingappa, R. H., Gangaplara, A., Rajasekaran, R. A., Afzal, M. Z., Khalilzad-Sharghi, V., Zhou, Y., Riethoven, J.-J., Nandi, S. S., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701090 · Cited by 17
Tada, Y., Ogawa, M., Watanabe, R., Zempo, H., Takamura, C., Suzuki, J.-I., Dan, T., Miyata, T., Isobe, M., & Komuro, I. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.855196 · Cited by 9
Metadata
- Authors
- Smith, S. C., & Allen, P. M.
- Venue
- Circulation Research
- Published
- 1992-04
- Volume
- 70
- Issue
- 4
- Pages
- 856-863
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2170985289
- Cited by
- 131
- References
- 0
- FWCI
- 6.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.